CDO1 and breast cancer: IHC analysis showed that CDO1 expression was nearly absent in hypermethylated BC tissues (n = 21), whereas it increased in hypomethylated NATs (n = 12), with H‐scores of .52 ± .60 and 209 ± 12.5, respectively (p < .0001) (Figure 2F).